Related Experiment Video

Updated: Aug 18, 2026

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis
06:19

Chinese Herbal Retention Enema for the Treatment of Ulcerative Colitis

Published on: May 16, 2025

[Guidelines for treatment of ulcerative colitis in children]

Takeshi Tomomasa1, ,

  • 1PAL Children's Clinic.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 11, 2005
PubMed

Insights

Pediatric ulcerative colitis treatment emphasizes intensive care during illness flares and cautious steroid use to prevent growth issues. Severe cases may benefit from pulsed steroids, apheresis, or cyclosporine.

Area of Science:

  • Pediatric Gastroenterology
  • Pediatric Inflammatory Bowel Disease

Background:

  • Ulcerative colitis (UC) treatment guidelines for children have been developed.
  • These guidelines address fundamental differences in medical treatment between pediatric and adult patients.

Purpose of the Study:

  • To outline specific recommendations for managing ulcerative colitis in children.
  • To highlight key considerations for acute phases, steroid use, and severe/fulminant cases in pediatric UC.

Main Methods:

  • Development of guidelines by a joint working group.
  • Focus on pediatric-specific treatment strategies for ulcerative colitis.

Main Results:

  • Intensive medical treatment and systemic management are crucial during the acute phase of pediatric UC.
  • Prolonged steroid therapy, which can impair growth, should be avoided.
  • Therapeutic options for severe and fulminant pediatric UC include pulsed steroid therapy, selective removal of blood cells (apheresis), and intravenous cyclosporine.

Conclusions:

  • Pediatric ulcerative colitis management requires tailored approaches distinct from adult protocols.
  • Early intensive treatment and judicious use of corticosteroids are vital for optimal outcomes in children.
  • Advanced therapies are available for managing severe pediatric ulcerative colitis cases.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...